Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69M Buy
600,000
+300,000
+100% +$1.87M 0.4% 34
2026
Q1
$1.48M Buy
300,000
+25,000
+9% +$128K 0.14% 36
2025
Q4
$1.61M Buy
275,000
+25,000
+10% +$208K 0.25% 43
2025
Q3
$1.51M Buy
250,000
+107,250
+75% +$509K 0.24% 47
2025
Q2
$558K Buy
142,750
+42,750
+43% +$139K 0.12% 62
2025
Q1
$308K Hold
100,000
– – 0.09% 56
2024
Q4
$531K Buy
100,000
+25,000
+33% +$126K 0.11% 59
2024
Q3
$344K Buy
75,000
+56,250
+300% +$296K 0.08% 76
2024
Q2
$134K Sell
18,750
-6,250
-25% -$46.8K 0.04% 58
2024
Q1
$213K Sell
25,000
-12,500
-33% -$108K 0.07% 59
2023
Q4
$222K Hold
37,500
– – 0.07% 50
2023
Q3
$372K Buy
37,500
+12,500
+50% +$173K 0.15% 54
2023
Q2
$440K Buy
+25,000
New +$488K 0.29% 36

Other funds holding CLNN

Scoggin Management's CLNN Position: Q2 2026 in Review

Scoggin Management increased its Clene (CLNN) stake by 100% in Q2 2026, buying an estimated $1.87M and bringing the position to 600,000 shares worth $3.69M. The position accounts for 0.4% of the portfolio, ranked #34.

Scoggin Management first reported a position in CLNN in Q2 2023 and has held it in 13 quarters since. 33 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.

  • Scoggin Management held 600,000 shares of Clene worth $3.69M as of Q2 2026.
  • Scoggin Management bought 300,000 Clene shares in Q2 2026, an estimated $1.87M.
  • Clene made up 0.4% of Scoggin Management's portfolio in Q2 2026, its #34 holding.
  • Scoggin Management first reported a position in Clene in Q2 2023 and has held it in 13 quarters since.
  • 33 funds tracked by Wall St. Rank held Clene as of Q2 2026.

Based on Scoggin Management's 13F filing for Q2 2026, filed 14 Aug 2026.